Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

Printer-friendly version
TitleIndolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Publication TypeJournal Article
Year of Publication2016
AuthorsKaminska, KK, Bertrand HC, Tajima H, Stafford WC, Cheng Q, Chen W, Wells G, Arner ESJ, Chew E-H
JournalOncotarget
Volume7
Issue26
Pagination40233-40251
Date Published06/2016
DOI10.18632/oncotarget.9579
Short TitleOncotarget
Unit: 
UMR 7203
Group: 
Equipe 1